Table 3. Summary of Serious Adverse Events and Adverse Events.
| Type of Adverse Event | Indwelling Pleural Catheter (n = 73) |
Talc Pleurodesis (n = 71) |
|---|---|---|
| Serious adverse events | ||
| Patients affected, No. (%) | 1 (1)a | 3 (4)b |
| No. of adverse events | ||
| Pleural infection | 2 | 1 |
| Cellulitis | 4 | 0 |
| Symptomatic loculation | 1 | 1 |
| Catheter blockage | 3 | 0 |
| Pneumothorax | 1 | 1 |
| Pain related to procedure | 6 | 4 |
| Worsening breathlessness | 4 | 6 |
| Tube dislodgement | 1 | 4 |
| Others | 7 | 3 |
| Total adverse events, No. | 29 | 20 |
| Total serious adverse events, No. | 1 | 3 |
| Total adverse and serious adverse events, No. | 30 | 23 |
| Patients affected by any adverse event, No. (%) | 22 (30) | 13 (18) |
a
One patient experienced a pulseless electrical activity cardiac arrest following indwelling pleural catheter insertion due to underlying cardiac disease but was successfully resuscitated without sequelae.
b
One patient died during surgery for a femoral fracture after a fall; 1 developed submassive pulmonary emboli; and 1 experienced severe chest pain requiring hospital admission.